Abstract:
BACKGROUND:Even though transurethral resection of the prostate remains the gold standard treatment for lower urinary tract symptoms (LUTS) refractory to medical therapy, photoselective vaporization of the prostate (PVP) has become a popular alternative. Early PVP studies seem encouraging, but few data exist regarding the effect of PVP on sexual function at long-term follow-up. OBJECTIVE:Our aim was to evaluate the impact of PVP on erectile function (EF) at long-term follow-up in men with LUTS due to benign prostatic hyperplasia (BPH). DESIGN, SETTING, AND PARTICIPANTS:One hundred forty-nine consecutive patients who underwent a prostate vaporization with the GreenLight laser performed by a single surgeon (FB) were prospectively enrolled in this study. INTERVENTION:All patients underwent PVP with the GreenLight laser performed by one experienced surgeon. MEASUREMENTS:All patients were evaluated by International Index of Erectile Function (IIEF-5) preoperatively and at 1, 3, 6, and 12 mo and then once a year. At each visit, the questionnaires were collected, and each patient's maximum flow rate and postvoid residual volume were measured with ultrasound. Biologic data were also collected at each visit, including prostate-specific antigen, creatinine, and bacterial urine culture. RESULTS AND LIMITATIONS:One hundred forty-nine patients were enrolled in the study. Median patient age was 74 yr. Urinary function was significantly improved over baseline in both men with normal or abnormal preoperative erectile function. Energy used was 255+/-129kJ. Hospitalization stay was 2.2+/-3.1 d. Other than a temporary difference at 1 yr, IIEF-5 scores were comparable preoperatively and postoperatively if we consider all the population. However, considering patients with preoperative IIEF-5 >19, the postoperative IIEF-5 scores were significantly decreased at 6, 12, and 24 mo. CONCLUSIONS:Sexual function appears to be maintained after PVP; however, in patients with normal preoperative EF, we showed a significant decrease in EF after PVP.
journal_name
Eur Uroljournal_title
European urologyauthors
Bruyère F,Puichaud A,Pereira H,Faivre d'Arcier B,Rouanet A,Floc'h AP,Bodin T,Brichart Ndoi
10.1016/j.eururo.2010.04.027subject
Has Abstractpub_date
2010-08-01 00:00:00pages
207-11issue
2eissn
0302-2838issn
1873-7560pii
S0302-2838(10)00386-6journal_volume
58pub_type
杂志文章相关文献
EUROPEAN UROLOGY文献大全abstract::Bony metastasis is a rare feature of metastatic nonseminomatous germ cell tumor. A 25 year-old man presented with back pain radiating down both legs, and a subsequent work-up demonstrated a right-sided testicular mass with bilateral retroperitoneal lymphadenopathy and tumor involvement of the L2 vertebra. Radical ingu...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2006.01.060
更新日期:2006-08-01 00:00:00
abstract:BACKGROUND:Prior studies assessing the correlation of Gleason score (GS) at needle biopsy and corresponding radical prostatectomy (RP) predated the use of the modified Gleason scoring system and did not factor in tertiary grade patterns. OBJECTIVE:To assess the relation of biopsy and RP grade in the largest study to d...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2012.01.050
更新日期:2012-05-01 00:00:00
abstract:BACKGROUND:The prognostic impact of primary tumor location on outcomes for patients with upper-tract urothelial carcinoma (UTUC) is still contentious. OBJECTIVE:To test the association between tumor location and disease recurrence and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2010.07.003
更新日期:2010-10-01 00:00:00
abstract::22 patients diagnosed as having bladder neck disease were evaluated retrospectively point of view. Urodynamic study including intravesical pressure, rectal pressure, intrinsic detrusor pressure and urine flow was performed in every case. A relation was established between the findings and the definite etiology. Two ur...
journal_title:European urology
pub_type: 杂志文章
doi:
更新日期:1982-01-01 00:00:00
abstract::The origin, differential diagnosis and therapy of rare testicular tumors are reviewed. 5% of all testicular tumors are rare tumors. Most of these rare tumors are of non-germ cell origin. ...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000472622
更新日期:1986-01-01 00:00:00
abstract:OBJECTIVE:Extracorporeal shock wave lithotripsy (SWL) treatment of radiolucent ureteric calculi (UC) is hampered by the reduced visibility of the stone. Intravenous contrast medium (IV-CM) administration may overcome this problem by indirectly depicting the localisation of the stone. However, IV-CM administration bears...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000052436
更新日期:2001-02-01 00:00:00
abstract::The dynamic obstruction of the bladder outlet secondary to benign prostatic hyperplasia (BPH), and the contractile properties of the human prostate are mediated primarily by alpha1-adrenoceptors. There are now at least three subtypes (A, B, and D) of alpha1-adrenoceptors, and recent work revealed that alpha1A-adrenoce...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000052315
更新日期:1999-01-01 00:00:00
abstract:BACKGROUND:Incontinence has a greater detrimental effect on quality of life than other symptoms of overactive bladder (OAB) and is often difficult to treat with antimuscarinic monotherapy. OBJECTIVE:To evaluate the efficacy and the safety and tolerability of combination (solifenacin 5mg and mirabegron 50mg) versus sol...
journal_title:European urology
pub_type: 杂志文章,多中心研究
doi:10.1016/j.eururo.2016.02.030
更新日期:2016-07-01 00:00:00
abstract:OBJECTIVES AND METHODS:In a retrospective analysis, the medical records of 166 patients over 80 years of age (80-99 years, mean age 82 years) who underwent transurethral prostatectomy (TURP) for clinically benign prostatic hyperplasia (BPH) were reviewed in order to evaluate the morbidity and mortality rates in this sp...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000474208
更新日期:1996-01-01 00:00:00
abstract:CONTEXT:Clinical data supporting the use of targeted agents for the treatment of metastatic renal cell carcinoma (RCC) are based predominantly on patients with clear cell histology. Little is known about the efficacy of these drugs in non-clear cell variants. OBJECTIVE:To evaluate the efficacy of different clear cell ...
journal_title:European urology
pub_type: 杂志文章,meta分析,评审
doi:10.1016/j.eururo.2014.05.010
更新日期:2015-04-01 00:00:00
abstract:OBJECTIVE:The authors present demographic and surgical data from a randomized phase III trial, instituted by the EORTC Genitourinary Group in 1988, the aim of which was to assess whether complete lymph node dissection in conjunction with radical nephrectomy for renal cell cancer is more effective than radical nephrecto...
journal_title:European urology
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1159/000020050
更新日期:1999-12-01 00:00:00
abstract::Antimuscarinics are commonly used to treat overactive bladder, but increase anticholinergic burden, which has been associated with multiple adverse outcomes in older patients. We advocate for standardization of anticholinergic risk assessment and reevaluation of anticholinergic prescribing practices for the elderly. ...
journal_title:European urology
pub_type: 社论
doi:10.1016/j.eururo.2019.03.021
更新日期:2019-07-01 00:00:00
abstract:CONTEXT:High-intensity focussed ultrasound (HIFU) is an emerging minimally invasive treatment option for prostate cancer. OBJECTIVE:Our aim was to assess the efficacy and safety of HIFU in both primary treatment of men with localised and locally advanced prostate cancer as well as salvage treatment of men with recurre...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1016/j.eururo.2010.09.009
更新日期:2010-12-01 00:00:00
abstract:OBJECTIVES:Prostaglandin E2 (PGE2) is a potent immune modulator and known to suppress both tumour antigen-specific helper T (TH1) cells and the generation of cytotoxic T lymphocytes (CTLs). We hypothesised that a combination of the cyclooxygenase 2 (COX-2) selective inhibitor celecoxib and intravesical bacillus Calmett...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2008.01.013
更新日期:2008-09-01 00:00:00
abstract:BACKGROUND:Many men (21-52%) are reported to have no cancer on the second, also known as the confirmatory, biopsy (B2) for prostate cancer active surveillance (AS). If these men had a reduced risk of pathologic progression, particularly grade related, the intensity of their follow-up could be decreased. OBJECTIVE:To i...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2013.04.038
更新日期:2014-09-01 00:00:00
abstract::12 patients have been treated for priapism between March 1973 and September 1977. Etiologic conditions have been found 9 times, leaving only 3 idiopathic priapisms. Treatment of choice consisted of 8 saphenocavernous shunts, achieving detumescence in 7 cases and preserving sexual potency in 5. The precocity of operati...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000473100
更新日期:1979-01-01 00:00:00
abstract:OBJECTIVE:The discovery of a novel estrogen receptor (ER), ER-beta, has given rise to new possibilities regarding estrogen's roles in the prostate. Although ER-beta is reported to be expressed preferentially in the rat prostate, its expression in the human prostate and relationship to cancer development has not been in...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000020345
更新日期:2000-11-01 00:00:00
abstract:CONTEXT:Previous studies have reported significant variation in prostate cancer rates and trends mainly due to differences in detection practices, availability of treatment, and underlying genetic susceptibility. OBJECTIVE:To assess recent worldwide prostate cancer incidence, mortality rates, and trends using up-to-da...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1016/j.eururo.2019.08.005
更新日期:2020-01-01 00:00:00
abstract::27 patients with recurrent low-grade, low-stage transitional cell carcinoma (TCC) of the bladder and uni- or bilateral vesico-ureteral reflux were followed for up to 18 years in order to study a possible higher incidence of TCC of the upper tract. None of the patients developed tumours of the upper collecting system d...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000472439
更新日期:1985-01-01 00:00:00
abstract:OBJECTIVES:To determine the incidence and clinical relevance of newly diagnosed cases of prostate cancer in a group of men who had an elevated PSA and benign prostate biopsy 7 years previously. PATIENTS AND METHOD:Patients under the age of 80 years with an elevated PSA who had had a benign prostate biopsy in the 12 mo...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/s0302-2838(03)00205-7
更新日期:2003-07-01 00:00:00
abstract:OBJECTIVE:evaluation of a self-injection program with a mixture of papaverine, phentolamine and prostaglandin E1 (PGE1). METHOD:a self-injection program for erectile dysfunction was started by 48 patients, using a 1-ml mixture of 4.5 mg papaverine, 0.2 mg phentolamine and 1.5 micrograms PGE1. Patients completed a ques...
journal_title:European urology
pub_type: 临床试验,杂志文章
doi:10.1159/000475407
更新日期:1994-01-01 00:00:00
abstract::Pain is the most common symptom of any illness; the physician's therapeutic task is twofold: to discover and treat the cause of pain and the pain itself, whether or not the underlying cause is treatable, to provide relief and reduce the suffering caused by pain. Although we use the term of pain to define all sensation...
journal_title:European urology
pub_type: 指南,杂志文章,实务指引
doi:10.1016/s0302-2838(03)00321-x
更新日期:2003-10-01 00:00:00
abstract:OBJECTIVE:In patients with prostate cancer, extended pelvic lymph node dissection (ePLND) yields a higher number of lymph node metastases (LNM) than standard pelvic lymph node dissection (PLND) of the obturator fossa only. We describe our laparoscopic technique of extended lymph node dissection and provide the number a...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2007.04.073
更新日期:2007-11-01 00:00:00
abstract::Blind-ending bifid ureters, as one type of duplications, are a rare congenital anomaly of the urinary tract. Occasionally they present with unspecific symptoms and require surgical intervention. This case of a blind-ending bifid ureter was associated with an intravesical ectopic orifice. Recurrent urinary tract infect...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000463849
更新日期:1984-01-01 00:00:00
abstract:CONTEXT:Enhanced recovery after surgery (ERAS) protocols aim to improve surgical outcomes by reducing variation in perioperative best practices. However, among published studies, results show a striking variation in the effect of ERAS pathways on perioperative outcomes after cystectomy. OBJECTIVE:To perform a systemat...
journal_title:European urology
pub_type: 杂志文章,meta分析,评审
doi:10.1016/j.eururo.2016.05.031
更新日期:2016-12-01 00:00:00
abstract:BACKGROUND:It is unknown whether lymph node metastases (LNM) and their localization negatively affect clinical outcome in metastatic renal cell carcinoma (mRCC) patients. OBJECTIVE:To evaluate the clinicopathological features, survival outcome, and treatment response in mRCC patients with LNM versus those without LNM ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2014.11.054
更新日期:2015-09-01 00:00:00
abstract::Combined androgen blockade (CAB) is becoming standard treatment for patients with newly diagnosed advanced prostate cancer. This statement is based on the outcome and long-term evaluation of patients treated in prospective randomised trials. Particularly, patients with 'good' prognostic signs at the time of diagnosis ...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000473836
更新日期:1996-01-01 00:00:00
abstract:OBJECTIVES:To examine the association between the complexed-to-total (C:T) prostate-specific antigen (PSA) ratio and prostate cancer pathological stage to assess whether the C:T PSA ratio may predict the final pathological stage in patients with clinically localized prostate cancer. PATIENTS AND METHODS:In a prospecti...
journal_title:European urology
pub_type: 临床试验,杂志文章
doi:10.1016/s0302-2838(03)00149-0
更新日期:2003-06-01 00:00:00
abstract:BACKGROUND:The combination of bevacizumab plus interferon (BEV+IFN) for treatment of metastatic renal cell carcinoma (mRCC) is associated with improved progression-free survival (PFS) in a phase 3 study. OBJECTIVE:To develop a novel model for prediction of individual PFS using data from the randomized, controlled phas...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2010.12.011
更新日期:2011-07-01 00:00:00
abstract:BACKGROUND:Studies offer wide variations in inclusion criteria for active surveillance (AS) in prostate cancer (PCa), but the role of the biopsy core number has not been thoroughly assessed. OBJECTIVE:To evaluate the impact of the biopsy core number on the risk of misclassification for AS eligibility. DESIGN, SETTING...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2009.07.053
更新日期:2009-12-01 00:00:00